Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives $54.83 Average Price Target from Analysts

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) have received an average recommendation of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $54.83.

A number of equities research analysts have recently commented on ESTA shares. BTIG Research initiated coverage on shares of Establishment Labs in a research note on Friday, May 16th. They set a "buy" rating and a $62.00 price objective on the stock. Wall Street Zen upgraded Establishment Labs from a "sell" rating to a "hold" rating in a research report on Saturday. Citigroup increased their target price on Establishment Labs from $38.00 to $47.00 and gave the company a "neutral" rating in a research report on Wednesday, July 9th. Mizuho increased their target price on Establishment Labs from $58.00 to $70.00 and gave the company an "outperform" rating in a research report on Wednesday, July 16th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $48.00 target price on shares of Establishment Labs in a research report on Friday, June 13th.

Establishment Labs Stock Performance

Shares of NASDAQ ESTA traded down $0.74 during midday trading on Wednesday, reaching $42.41. 302,751 shares of the stock were exchanged, compared to its average volume of 325,433. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -13.68 and a beta of 0.80. Establishment Labs has a twelve month low of $26.56 and a twelve month high of $50.85. The firm has a 50-day simple moving average of $39.91 and a two-hundred day simple moving average of $36.71. The company has a quick ratio of 2.05, a current ratio of 3.36 and a debt-to-equity ratio of 5.72.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.13. The business had revenue of $41.38 million for the quarter, compared to analysts' expectations of $41.15 million. Establishment Labs had a negative net margin of 52.34% and a negative return on equity of 196.25%. The business's revenue was up 11.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.58) EPS. As a group, analysts anticipate that Establishment Labs will post -2.41 EPS for the current fiscal year.

Institutional Trading of Establishment Labs

A number of hedge funds have recently bought and sold shares of the business. Patriot Financial Group Insurance Agency LLC raised its holdings in Establishment Labs by 5.2% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company's stock valued at $257,000 after acquiring an additional 300 shares during the last quarter. Raymond James Financial Inc. increased its holdings in shares of Establishment Labs by 0.4% during the 1st quarter. Raymond James Financial Inc. now owns 119,752 shares of the company's stock worth $4,886,000 after buying an additional 491 shares during the last quarter. Swiss National Bank increased its holdings in shares of Establishment Labs by 1.3% during the 1st quarter. Swiss National Bank now owns 39,000 shares of the company's stock worth $1,591,000 after buying an additional 500 shares during the last quarter. Quarry LP acquired a new stake in shares of Establishment Labs during the 4th quarter worth approximately $27,000. Finally, CWM LLC increased its holdings in shares of Establishment Labs by 45.9% during the 2nd quarter. CWM LLC now owns 2,182 shares of the company's stock worth $93,000 after buying an additional 686 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.